Trial NCT02213042

View at ClinicalTrials.gov 
Org. Study IDs: 117165
Secondary IDs: 2014-001220-30 CLAP016A2206

Last trial update was posted on 2021-10-13

MeSH Interventions

Aromatase Inhibitors Lapatinib Trastuzumab

MeSH Conditions

Breast Neoplasms

Other Conditions

Neoplasms, Breast

Stopping Reasons

Primary analysis was completed in 2018 and continued minimal data collection from the one participant active in the study was not expected to add meaningful knowledge to the understanding of lapatinib

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID